Suspension for doping: Facundo Bagnis caught by positive test at US Open

The 35-year-old player, finalist in Cordoba last year, has accepted a provisional suspension after a positive test at the US Open. He claims he will prove his innocence.

A new doping case within the men's tour. Argentine Facundo Bagnis, former world No. 55, has accepted a provisional suspension following a positive test recorded during the first round of qualifying at the last US Open.

Hydrochlorothiazide was found in one of the samples, a diuretic medication that among other things is used to treat high blood pressure.

Since Bagnis did not have a Therapeutic Use Exemption (TUE), he therefore began a provisional suspension on October 18th.

A two-time finalist on the ATP Tour (Santiago 2021 and Cordoba 2024), the 35-year-old player reacted to this news via a statement:

"This news completely took me by surprise. I am collaborating transparently with the ITIA to clarify this matter as quickly as possible. Furthermore, I have accepted a provisional suspension in order to devote all my attention to this process and to demonstrate that I have nothing to hide.

I want to clarify that I have never intentionally taken a banned substance. That is why I feel completely innocent. The truth will eventually come out with a just outcome.

With a team of doctors, toxicologists, and lawyers working by my side, we suspect cross-contamination and we are doing everything possible for the truth to be established. That is our primary goal today."

Bagnis's last appearance dates back to a withdrawal in the second round of the Antofagasta Challenger in early October.